GlassScriptPhysician profile
John R Dowling
NPI 1801277108
$6,431.61
in general payments reported to CMS, 2019-2025
16 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,295 · 2022: $4,371 · 2023: $326 · 2024: $315 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.99 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $4,240.00 | 2022 | |
| Novo Nordisk INC | $415.31 | 2021-2024 | |
| Lilly USA, LLC | $399.14 | 2021-2024 | Zepbound |
| Insulet Corporation | $241.61 | 2023-2025 | Omnipod, Omnipod |
| Medtronic, INC. | $208.89 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $164.40 | 2021 | |
| Sanofi-Aventis U.S. LLC | $130.51 | 2021 | |
| Tandem Diabetes Care, INC. | $105.21 | 2021 | |
| Ascensia Diabetes Care US INC. | $99.02 | 2023 | |
| Amgen INC. | $95.00 | 2024 | Evenity |
| Dexcom, INC. | $82.67 | 2021-2022 | |
| Abbott Laboratories | $75.94 | 2022-2023 | Freestyle Libre 3 |
| Mannkind Corporation | $59.40 | 2023 | Afrezza |
| Corcept Therapeutics | $55.12 | 2022 | |
| Xeris Pharmaceuticals, INC. | $37.83 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.